Items where Author or Contributor is "Foster, GR"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Year | Item Type | Full Text
Jump to: 2016 | 2014 | 2013 | 2012 | 2011 | 2010
Number of items: 11.

2016

Martin, NK; Vickerman, P; Dore, GJ; Grebely, J; Miners, A; Cairns, J; Foster, GR; Hutchinson, SJ; Goldberg, DJ; Martin, TC; +3 more... Ramsay, M; STOP-HCV Consortium; Hickman, M; (2016) How should HCV treatment be prioritized in the direct-acting antiviral era? An economic evaluation including population prevention benefits. Journal of hepatology, 65 (1). pp. 17-25. ISSN 0168-8278 DOI: https://doi.org/10.1016/j.jhep.2016.02.007 Full text not available from this repository.

2014

Martin, NK; Devine, A; Eaton, JW; Miners, A; Hallett, TB; Foster, GR; Dore, GJ; Easterbrook, PJ; Legood, R; Vickerman, P; (2014) Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa. AIDS (London, England), 28 Sup. S35-46. ISSN 0269-9370 DOI: https://doi.org/10.1097/QAD.0000000000000084 Full text not available from this repository.

Martin, NK; Foster, GR; Vilar, J; Ryder, S; Cramp, ME; Gordon, F; Dillon, JF; Craine, N; Busse, H; Clements, A; +10 more... Hutchinson, SJ; Ustianowski, A; Ramsay, M; Goldberg, DJ; Irving, W; Hope, V; De Angelis, D; Lyons, M; Vickerman, P; Hickman, M; (2014) HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact. Journal of viral hepatitis, 22 (4). pp. 399-408. ISSN 1352-0504 DOI: https://doi.org/10.1111/jvh.12338
[img]

Williams, R; Aspinall, R; Bellis, M; Camps-Walsh, G; Cramp, M; Dhawan, A; Ferguson, J; Forton, D; Foster, G; Gilmore, I; +15 more... Hickman, M; Hudson, M; Kelly, D; Langford, A; Lombard, M; Longworth, L; Martin, N; Moriarty, K; Newsome, P; O'Grady, J; Pryke, R; Rutter, H; Ryder, S; Sheron, N; Smith, T; (2014) Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet, 384 (9958). pp. 1953-97. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(14)61838-9 Full text not available from this repository.

2013

Martin, NK; Vickerman, P; Clements, A; Cramp, M; de Angeles, D; Dillon, JF; Fahey, S; Foster, GR; Goldberg, DJ; Gordon, F; +7 more... Hutchinson, SJ; Irving, W; Lewis, H; Ryder, S; Ustainowski, A; Vilar, J; Hickman, M; (2013) ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/1229346 Full text not available from this repository.

Martin, NK; Vickerman, P; Grebely, J; Hellard, M; Hutchinson, SJ; Lima, VD; Foster, GR; Dillon, JF; Goldberg, DJ; Dore, GJ; +1 more... Hickman, M; (2013) HCV treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. Hepatology (Baltimore, Md), 58 (5). pp. 1598-609. ISSN 0270-9139 DOI: https://doi.org/10.1002/hep.26431 Full text not available from this repository.

Martin, NatashaK; Vickerman, Peter; Grebely, Jason; Hellard, Margaret; Hutchinson, SharonJ; Lima, VivianeD; Foster, GrahamR; Dillon, JohnF; Goldberg, DavidJ; Dore, GregoryJ; +1 more... Hickman, Matthew; (2013) Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals. Hepatology (Baltimore, Md), 58 (5). pp. 1598-1609. ISSN 0270-9139 DOI: https://doi.org/10.1002/hep.26431
[img]

2012

Harris, RJ; Ramsay, M; Hope, VD; Brant, L; Hickman, M; Foster, GR; De Angelis, D; (2012) Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. European journal of public health, 22 (2). pp. 187-92. ISSN 1101-1262 DOI: https://doi.org/10.1093/eurpub/ckr083 Full text not available from this repository.

2011

Martin, NK; Vickerman, P; Foster, GR; Hutchinson, SJ; Goldberg, DJ; Hickman, M; (2011) Can antiviral therapy for Hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. Journal of hepatology, 54 (6). pp. 1137-44. ISSN 0168-8278 DOI: https://doi.org/10.1016/j.jhep.2010.08.029 Full text not available from this repository.

Martin, NK; Vickerman, P; Miners, A; Foster, GR; Hutchinson, SJ; Goldberg, DJ; Hickman, M; (2011) The cost-effectiveness of HCV antiviral treatment for injecting drug user populations. Hepatology (Baltimore, Md), 55 (1). pp. 49-57. ISSN 0270-9139 DOI: https://doi.org/10.1002/hep.24656 Full text not available from this repository.

2010

This list was generated on Wed Oct 16 06:47:31 2019 BST.